February 2011 | Oncology & Biotech News

Prereferral Treatment of Head and Neck Cancer Patients Disregards Guidelines

March 16, 2011

New findings indicate that prereferral care does not conform to clinical practice guidelines in nearly half of patients with head and neck cancer who are referred to a tertiary care center with persistent or recurrent disease, new findings indicate.

ASCO GI Coverage: Everolimus Associated With Significant PFS Improvement in Patients With PNETs

March 13, 2011

Data from a large randomized trial showed that treatment with the targeted agent everolimus was associated with a 65% improvement in progression-free survival (PFS) in patients with advanced pancreatic neuroendocrine tumors (PNETs).